Related Experiment Video
Updated: Jul 4, 2026
07:21
Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
Gastrointestinal stromal tumours: an update.
N de S Somerhausen1, C D Fletcher
1Department of Pathology Brigham and Women's Hospital and Harvard Medical School 75 Francis Street Boston MA 02115 USA.
Sarcoma
|June 4, 2008
Summary
Gastrointestinal stromal tumours (GISTs) concepts evolved over 30 years. Advances in diagnostics like immunohistochemistry and c-Kit mutation analysis clarified GIST origins and improved patient management.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Gastrointestinal stromal tumours (GISTs) have presented diagnostic challenges for over three decades.
- Controversies existed regarding their differentiation and behavior prediction.
- Peritoneal GIST metastasis is notoriously difficult to manage.
Purpose of the Study:
- To chronologically review the conceptual evolution of GISTs over 30 years.
- To examine the impact of diagnostic advancements on GIST understanding.
- To discuss how these advancements influence pathological assessment and clinical care.
Main Methods:
- Review of scientific literature and diagnostic techniques over a 30-year period.
- Analysis of the application of electron microscopy, immunohistochemistry, and DNA ploidy analysis.
- Chronological examination of evolving GIST classification and understanding.
Main Results:
- Identification of c-Kit mutations and KIT/CD117 expression as key diagnostic markers.
- Reappraisal of GISTs as originating from interstitial cells of Cajal (with exceptions).
- Improved definition of the pathological spectrum of GISTs.
Conclusions:
- Diagnostic advancements have significantly refined the understanding of GISTs.
- The identification of KIT/CD117 has been pivotal in GIST diagnosis and classification.
- Enhanced diagnostic capabilities have led to improved pathological assessment and clinical management strategies for GISTs.
